Accretio – Realising the value of rough diamonds
M&A and diversification have left pharma portfolios with an abundance of underinvested medicines, but they needn't be ignored
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
